Association of modifiers and other genetic factors explain Marfan syndrome clinical variability.

Eur J Hum Genet 2018 12 7;26(12):1759-1772. Epub 2018 Aug 7.

Laboratory for Vascular Translational Science, INSERM U1148, DHU FIRE, Centre Hospitalo-Universitaire Xavier Bichat (APHP), 46 rue Henri Huchard, Paris, 75018, France.

Marfan syndrome (MFS) is a rare autosomal dominant connective tissue disorder related to variants in the FBN1 gene. Prognosis is related to aortic risk of dissection following aneurysm. MFS clinical variability is notable, for age of onset as well as severity and number of clinical manifestations. To identify genetic modifiers, we combined genome-wide approaches in 1070 clinically well-characterized FBN1 disease-causing variant carriers: (1) an FBN1 eQTL analysis in 80 fibroblasts of FBN1 stop variant carriers, (2) a linkage analysis, (3) a kinship matrix association study in 14 clinically concordant and discordant sib-pairs, (4) a genome-wide association study and (5) a whole exome sequencing in 98 extreme phenotype samples.Three genetic mechanisms of variability were found. A new genotype/phenotype correlation with an excess of loss-of-cysteine variants (P = 0.004) in severely affected subjects. A second pathogenic event in another thoracic aortic aneurysm gene or the COL4A1 gene (known to be involved in cerebral aneurysm) was found in nine individuals. A polygenic model involving at least nine modifier loci (named gMod-M1-9) was observed through cross-mapping of results. Notably, gMod-M2 which co-localizes with PRKG1, in which activating variants have already been described in thoracic aortic aneurysm, and gMod-M3 co-localized with a metalloprotease (proteins of extra-cellular matrix regulation) cluster. Our results represent a major advance in understanding the complex genetic architecture of MFS and provide the first steps toward prediction of clinical evolution.

Download full-text PDF

Source Listing
December 2018
34 Reads
1 Citation
4.350 Impact Factor

Publication Analysis

Top Keywords

thoracic aortic
association study
clinical variability
aortic aneurysm
marfan syndrome
variant carriers
correlation excess
excess loss-of-cysteine
genotype/phenotype correlation
loss-of-cysteine variants
variability genotype/phenotype
samplesthree genetic
genetic mechanisms
mechanisms variability
gene col4a1
variants p = 0004
second pathogenic
pathogenic event
event thoracic
subjects second

Altmetric Statistics


(Supplied by CrossRef)

L Faivre et al.
J Med Genet 2008

L Faivre et al.
Pediatrics 2009

LM Baudhuin et al.
Genet Med J Am Coll Med Genet 2015

R Franken et al.
Eur Heart J 2016

M Aubart et al.
Hum Mol Genet 2015

A Paepe De et al.
Am J Med Genet 1996

BL Loeys et al.
J Med Genet 2010

MJ Roman et al.
Am J Cardiol 1989

R Erbel et al.
Eur Heart J 2014

Similar Publications